Tomoo Itoh
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Drug Transport and Resistance Mechanisms
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Co-authors
- Hiroyuki Katoh (16 shared papers)Taro Oshikiri (11 shared papers)Kei Hiraoka (10 shared papers)Masato Suzuoki (9 shared papers)Yoshihiro Nakakubo (9 shared papers)Satoshi Kondo (13 shared papers)Masaki Miyamoto (13 shared papers)Yoh Zen (29 shared papers)
- Journals
- Pathology International (15 papers)Human Pathology (9 papers)Histopathology (9 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (9 papers)Neuropathology (9 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tomoo Itoh
295 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 118
- Oncology 2k
- Pharmacology 479
- Genetics 273
- Pulmonary and Respiratory Medicine 833
- Surgery 1.1k
Countries citing papers authored by Tomoo Itoh
This map shows the geographic impact of Tomoo Itoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoo Itoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoo Itoh more than expected).
Fields of papers citing papers by Tomoo Itoh
This network shows the impact of papers produced by Tomoo Itoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoo Itoh. The network helps show where Tomoo Itoh may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomoo Itoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 307 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 456 | |
| 2 | 2006 | 405 | |
| 3 | 2003 | 284 | |
| 4 | CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. | 2003 | 225 |
| 5 | 2002 | 214 | |
| 6 | 2001 | 134 | |
| 7 | 2003 | 133 | |
| 8 | 2002 | 127 | |
| 9 | 2003 | 122 | |
| 10 | 2017 | 110 | |
| 11 | 2003 | 97 | |
| 12 | 2000 | 94 | |
| 13 | 2013 | 92 | |
| 14 | 2003 | 84 | |
| 15 | 2008 | 77 | |
| 16 | 2002 | 73 | |
| 17 | 2003 | 71 | |
| 18 | 2002 | 64 | |
| 19 | 2004 | 62 | |
| 20 | 2013 | 62 |
About Tomoo Itoh
Tomoo Itoh is a scholar working on Oncology, Surgery, Pharmacology, Pulmonary and Respiratory Medicine and Genetics, having authored 307 papers that have together received 6.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Lung Cancer Research Studies (16 papers), Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (15 papers), Esophageal Cancer Research and Treatment (13 papers), Glioma Diagnosis and Treatment (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Oncology (2k citations), Pharmacology (479 citations), Genetics (273 citations), Pulmonary and Respiratory Medicine (833 citations) and Surgery (1.1k citations). Tomoo Itoh has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroyuki Katoh, Taro Oshikiri, Kei Hiraoka, Masato Suzuoki, Yoshihiro Nakakubo, Satoshi Kondo, Masaki Miyamoto, Yoh Zen, Ryoichi Fujiwara and Masataka Miyamoto. Their work appears in journals such as Pathology International, Human Pathology, Histopathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Neuropathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.